Table 5.
Prediction of outcome measures by AGREE domain scores
| Outcome measure | AGREE domain no.* | Type III sum of squares F statistic p value | Parameter estimate (95% CI) |
|---|---|---|---|
| Endorse (I would recommend this guideline for use in practice) | 1 | < 0.001 | 0.01 (−0.02 to 0.05) |
| 2 | < 0.001 | 0.01 (−0.02 to 0.05) | |
| 3 | < 0.001 | 0.08 (0.02 to 0.13) | |
| 4 | < 0.001 | 0.04 (0.0 to 0.08) | |
| 5 | 0.014 | 0.01 (−0.02 to 0.04) | |
| 6 | 0.155 | NA | |
| Intend to use (I would make use of a guideline of this quality in my professional decisions) | 1 | 0.001 | 0.01 (−0.03 to 0.04) |
| 2 | < 0.001 | 0.01 (−0.03 to 0.04) | |
| 3 | < 0.001 | 0.06 (0.0 to 0.12) | |
| 4 | < 0.001 | 0.05 (0.01 to 0.09) | |
| 5 | 0.044 | 0.02 (−0.01 to 0.05) | |
| 6 | 0.186 | NA | |
| Overall quality (Rate the overall quality of this guideline) | 1 | < 0.001 | 0.01 (−0.01 to 0.04) |
| 2 | < 0.001 | 0.01 (−0.02 to 0.03) | |
| 3 | < 0.001 | 0.05 (0.01 to 0.08) | |
| 4 | < 0.001 | 0.03 (0.0 to 0.06) | |
| 5 | 0.008 | 0.01 (−0.01 to 0.03) | |
| 6 | 0.052 | NA |
Note: CI = confidence interval, NA = not applicable.
*
Domain names, by number, are: 1 = Scope and purpose, 2 = Stakeholder involvement, 3 = Rigour of development, 4 = Clarity of presentation, 5 = Applicability, 6 = Editorial independence.